MTTP p.Arg540Cys
c.1618C>T · rs372321643 · VCV840396
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7277 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.969 | strongly pathogenic-leaning |
| SaProt | LLR -11.52 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 5.8 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 48 kb · p 0.00018 · regional, not allelic |
| Overall | ||
| CADD | 27.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0164% | 6,082 |
| Admixed American | 0.00667% | 15,000 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,241 |
| African / African-American | 0.00267% | 37,455 |
| European (non-Finnish) | 0.00263% | 38,064 |
| South Asian | 0.0022% | 45,544 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MTTP
- Protein
- p.Arg540Cys
- Coding
- c.1618C>T
- MANE Select
- NM_001386140
- dbSNP
- rs372321643
- Type
- single nucleotide variant
- Location
- chr4:99608826 (GRCh38)
- Gene constraint
- LOEUF 0.672 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 86.73 · 2 PDB
- Residue 540
- a UniProt-annotated variant site (in abl; does not reduce interaction with p4hb/pdi and apob; inhibits triglyceride transfer activity); a UniProt-annotated variant site (in abl; no loss on localization to the endoplasmic reticulum; reduces interaction with p4hb/pdi; inhibits phospholipid or triglyceride transfer activity; inhibits apolipoprotein b secretion); the vitellogenin domain; an α-helix
Disease context
abetalipoproteinemia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Abetalipoproteinemia (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- MTTP p.Arg540His Pathogenic/Likely pathogenic ★★ same residue
- MTTP c.1067+1G>C Likely pathogenic ★★ same condition
- MTTP c.1769+2T>C Pathogenic/Likely pathogenic ★★ same condition
- MTTP c.1867+1G>A Pathogenic ★★ same condition
- MTTP c.1867+5G>A Pathogenic/Likely pathogenic ★★ same condition
- MTTP c.1868-2A>G Likely pathogenic ★★ same condition
- MTTP c.2342+1G>A Pathogenic ★★ same condition
- MTTP c.502-1G>C Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mttp-p-arg540cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown